Mindfulness Psychoeducation Program for Schizophrenia

Last updated: August 14, 2018
Sponsor: The Hong Kong Polytechnic University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Schizophrenia And Schizoaffective Disorders

Tourette's Syndrome

Mood Disorders

Treatment

N/A

Clinical Study ID

NCT03632278
HSEARS20180531001
  • Ages 18-65
  • All Genders

Study Summary

The study is the first pilot randomised controlled trial (RCT) to explore the feasibility and efficacy of Mindfulness-based psychoeducation in emotion regulation and related depressive and anxiety symptoms in people with schizophrenia.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Aged 18 years to 65 years old

  • Diagnosis with schizophrenia-spectrum disorders according to the criteria of theDiagnostic and Statistical Manual for Mental Disorders DSM-IV-TR (and the latestDSM-V) or International Classification of Diseases (ICD-10)-Classification of MentalDisorders

  • Able to communicate in written and conversational Chinese/Cantonese

  • Able to understand the concepts of the study and to give informed consent

Exclusion

Exclusion Criteria:

  • Comorbid organic brain disorders or substance abuse

  • Participation in any forms of cognitive therapy

  • Participation and/or practice of mindfulness (in the forms of Tai Chi, Qi Gong, etc.)more than twice a week during the previous three months

Study Design

Total Participants: 58
Study Start date:
June 03, 2018
Estimated Completion Date:
December 31, 2019

Study Description

There is increasing evidence to demonstrate the safety and effectiveness of mindfulness-based psychoeducation programme (MBPP) for Chinese people with schizophrenia. A single-blind, multi-site, pragmatic randomised controlled trial conducted in Hong Kong, mainland China, and Taiwan with 300 participants consistently demonstrated significant improvement in regard to insight of illness, functioning, mental state and the length of re-hospitalisations when compared with conventional psychoeducation and Treatment As Usual (TAU) groups (Chien, 2017).

The study hypothesises that:

  1. Participants receiving MBPP will decrease their use of rumination and expressive suppression, and increase the use of cognitive reappraisal compared to a control group after completion of the intervention.

  2. Participants receiving MBPP attain a reduction in depressive/anxiety symptoms compared to a control group after completion of the intervention.

  3. These effects are expected to be maintained through 3-month follow up with regular self-practice.

Connect with a study center

  • New Life Assocation

    Hong Kong,
    Hong Kong

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.